Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Szkandera J, Stotz M, Absenger G, Stojakovic T, Samonigg H, Kornprat P, Schaberl-Moser R, Alzoughbi W, Lackner C, Ress AL, Seggewies FS, Gerger A, Hoefler G, Pichler M.
Szkandera J, et al. Among authors: lackner c.
Br J Cancer. 2014 Jan 7;110(1):183-8. doi: 10.1038/bjc.2013.701. Epub 2013 Nov 7.
Br J Cancer. 2014.
PMID: 24201751
Free PMC article.